Round Rock Advisors »

Esperion Therapeutics shares owned by Round Rock Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Round Rock Advisors from 13F filings

Historical chart of Round Rock Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Round Rock Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Round Rock Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $376k 102k 3.70

More positions owned by Round Rock Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Whitehall Fds High Div Yld (VYM)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Select Sector Spdr Tr State Street Ind (XLI)
Select Sector Spdr Tr State Street Hea (XLV)
Ishares Tr Select Divid Etf (DVY)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl A (BRK.A)
American Centy Etf Tr Short Durtn Strg (SDSI)
Alphabet Cap Stk Cl C (GOOG)
Neuberger Berman Etf Trust Short Duration I (NBSD)

View all positions for Round Rock Advisors

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
State Street Corporation
Geode Capital Management
Marshall Wace
PenderFund Capital Management
AIGH Capital Management
Eversept Partners
Nuveen
Royce & Associates
Goldman Sachs Group
Two Sigma Investments
Renaissance Technologies

View all funds holding Esperion Therapeutics